SYNACT PHARMA ApS: Financial statements 2021
CVR: 34459975
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
SYNACT PHARMA ApS (CVR 34459975) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -43,429,977 and a net result of DKK -41,156,629 compared with DKK -14,002,315 the year before. Equity in the 2021 report amounted to DKK 6,649,030. The solvency ratio was 49.1%. The company had 2 employees in the financial year.
- Gross Profit
- DKK -43,429,977
- Profit/Loss
- DKK -41,156,629
- Equity
- DKK 6,649,030
- Total Assets
- DKK 13,544,104
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -43.4 mio. | -41.2 mio. | 6.6 mio. | 2 |
| 2020 | - | -16.7 mio. | -14 mio. | 11.4 mio. | - |
| 2019 | - | -11.5 mio. | -9.8 mio. | -21.8 mio. | - |
| 2018 | - | -16.8 mio. | -13.6 mio. | -12 mio. | - |
| 2017 | - | -10 mio. | -8.3 mio. | 1.6 mio. | - |
Find more companies like SYNACT PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
SYNACT PHARMA ApS has published its annual report for 2020. Gross profit came to DKK -16,676,255, and the net result was DKK -14,002,315.
About SYNACT PHARMA ApS
SYNACT PHARMA ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2012. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SYNACTION PHARMA ApS. The management consists of Jeppe Øvli Øvlesen, Thomas Boesen and Ann Kristin Brøgger Led. The company is owned by SynAct Pharma AB. In 2025, the company reported a gross profit of DKK -53,194,923 and a net result of DKK -59,812,937 compared with DKK -30,477,376 the year before. Equity in the 2025 report amounted to DKK 20,295,649.